Matsubayashi, Hiroyuki
Higashigawa, Satomi
Kiyozumi, Yoshimi
Oishi, Takuma
Sasaki, Keiko
Ishiwatari, Hirotoshi
Imai, Kenichiro
Hotta, Kinichi
Yabuuchi, Yohei
Ishikawa, Kazuma
Satoh, Tatsunori
Ono, Hiroyuki
Todaka, Akiko
Kawakami, Takeshi
Shirasu, Hiromichi
Yasui, Hirofumi
Sugiura, Teichi
Uesaka, Katsuhiko
Kagawa, Hiroyasu
Shiomi, Akio
Kado, Nobuhiro
Hirashima, Yasuyuki
Kiyohara, Yoshio
Bando, Etsuro
Niwakawa, Masashi
Nishimura, Seiichiro
Aramaki, Takeshi
Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Horiuchi, Yasue
Serizawa, Masakuni
Article History
Received: 15 July 2021
Accepted: 4 January 2022
First Online: 17 January 2022
Declarations
:
: The institutional review board (IRB) of the Shizuoka Cancer Center ethically approved this study (IRB no. J2020–82), and all procedures were conducted in accordance with the Helsinki Declaration. All MSI tests were done with informed consent to the patients. As this study was a retrospective observation study of the clinical practice in Japan, informed consent was obtained using the opt-out approach according to the IRB policy.
: Not applicable.
: The authors declare that they have no competing interests.